Our Company’s Background
Our technology was developed in Dr. John Fahy’s airway biology laboratory at the University of California San Francisco (UCSF) in collaboration with Dr. Stefan Oscarson’s glycochemistry laboratory at University College Dublin and Dr. Anne Marie Healy’s pharmaceutics laboratory at Trinity College Dublin. The efforts of this research consortium have led to over $18M in NIH funding, resulting in the identification of our lead therapeutic candidate (AER-01), establishment of preliminary safety and efficacy profiles, and the production of clinical trial API.
Aer Therapeutics Team
We are led by an experienced management team with an established track record of success in the development of drug-candidates.
Management Team

Irina Gitlin, PhD
Vice President, Research and Development

Blair Capel
Director of Finance

Rony Nasrallah
Associate Director, Technical Operations

Jordan Low
Director of Clinical Operations
Board of Directors

John Fahy MD MSc
Founder

Rishi Gupta, JD
Partner, OrbiMed

Thomas P. Mathers
Executive Chairman

Christy Shaffer, PhD
Partner, Hatteras Ventures

Tim Shannon, MD
Partner, Canaan Partners
Investors


